Loading clinical trials...
Loading clinical trials...
This study will evaluate the long term safety and efficacy of pregabalin (Lyrica) when administered by itself (without any other anti-epileptic medication) to epilepsy patients for the treatment of pa...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
NCT06608966 · Epilepsy in Children, Executive Dysfunction
NCT06455384 · Cardiac Conditions, Connective Tissue Diseases, and more
NCT05140265 · Epilepsy, Status Epilepticus, and more
NCT06059157 · Drug Resistant Epilepsy
NCT07116421 · Epilepsy, Sudden Unexpected Death in Epilepsy
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Fayetteville, Arkansas
Pfizer Investigational Site
Fullerton, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions